PharmEasy FY24 results: Revenue falls nearly 15%, losses narrow by 51%

Online pharmacy startup PharmEasy has recorded a 14.7 per cent decline in its consolidated revenue from operations to Rs 5,664 crore in the financial year 2023-24 from Rs 6,643 crore in FY23. The total income dropped to Rs 5,758 crore in FY24 from Rs 6,699 crore in FY23, according to the results published by PharmEasy’s parent company API Holdings on its website. The startup competes with Tata’s 1MG, Netmeds, Apollo Pharmacy, Trumeds, and marketplaces such as Flipkart Health+ and Amazon Pharmacy.